Literature DB >> 16029059

Nanotechnology-based drug delivery for cancer.

K K Jain1.   

Abstract

Nanobiotechnologies have been applied to improve drug delivery and to overcome some of the problems of drug delivery in cancer. These can be classified into many categories that include use of various nanoparticles, nanoencapsulation, targeted delivery to tumors of various organs, and combination with other methods of treatment of cancer such as radiotherapy. Nanoparticles are also used for gene therapy for cancer. Some of the technologies enable combination of diagnostics with therapeutics which will be important for the personalized management of cancer. Some of the limitations of these technologies and prospects for future development are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029059     DOI: 10.1177/153303460500400408

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  29 in total

1.  Partial wrapping and spontaneous endocytosis of spherical nanoparticles by tensionless lipid membranes.

Authors:  Eric J Spangler; Sudhir Upreti; Mohamed Laradji
Journal:  J Chem Phys       Date:  2016-01-28       Impact factor: 3.488

2.  Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Authors:  Huanyu Dou; Christopher J Destache; Justin R Morehead; R Lee Mosley; Michael D Boska; Jeffrey Kingsley; Santhi Gorantla; Larisa Poluektova; Jay A Nelson; Mahesh Chaubal; Jane Werling; James Kipp; Barrett E Rabinow; Howard E Gendelman
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

3.  Spray Dried Formulation of 5-Fluorouracil Embedded with Probiotic Biomass: In Vitro and In Vivo Studies.

Authors:  Anshul Sharma; Malika Arora; Amit K Goyal; Goutam Rath
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

4.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  From bench to bedside: the growing use of translational research in cancer medicine.

Authors:  Erin M Goldblatt; Wen-Hwa Lee
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 6.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

7.  In vivo toxicity studies of europium hydroxide nanorods in mice.

Authors:  Chitta Ranjan Patra; Soha S Abdel Moneim; Enfeng Wang; Shamit Dutta; Sujata Patra; Michal Eshed; Priyabrata Mukherjee; Aharon Gedanken; Vijay H Shah; Debabrata Mukhopadhyay
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-17       Impact factor: 4.219

8.  Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Authors:  Huanyu Dou; Cassi B Grotepas; JoEllyn M McMillan; Christopher J Destache; Mahesh Chaubal; Jane Werling; James Kipp; Barrett Rabinow; Howard E Gendelman
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

Review 9.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

10.  Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia.

Authors:  Costas G Hadjipanayis; Michael J Bonder; Srinivasan Balakrishnan; Xiaoxia Wang; Hui Mao; George C Hadjipanayis
Journal:  Small       Date:  2008-11       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.